These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19737543)

  • 41. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
    Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
    Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphodiesterase 7 as a therapeutic target - Where are we now?
    Zorn A; Baillie G
    Cell Signal; 2023 Aug; 108():110689. PubMed ID: 37120115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma membrane depolarization and Na,K-ATPase impairment induced by mitochondrial toxins augment leukemia cell apoptosis via a novel mitochondrial amplification mechanism.
    Yin W; Li X; Feng S; Cheng W; Tang B; Shi YL; Hua ZC
    Biochem Pharmacol; 2009 Jul; 78(2):191-202. PubMed ID: 19442964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders.
    Safavi M; Baeeri M; Abdollahi M
    Expert Opin Drug Discov; 2013 Jun; 8(6):733-51. PubMed ID: 23570245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of cyclic nucleotide phosphodiesterases type 3 and 4 in cardiac excitation-contraction coupling and arrhythmias].
    Mika D; Leroy J; Fischmeister R; Vandecasteele G
    Med Sci (Paris); 2013; 29(6-7):617-22. PubMed ID: 23859516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors.
    Meyers JA; Su DW; Lerner A
    J Immunol; 2009 May; 182(9):5400-11. PubMed ID: 19380787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example.
    Castro A; Jerez MJ; Gil C; Calderón F; Doménech T; Nueda A; Martínez A
    Eur J Med Chem; 2008 Jul; 43(7):1349-59. PubMed ID: 18082290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research.
    Jankowska A; Swierczek A; Chlon-Rzepa G; Pawlowski M; Wyska E
    Curr Med Chem; 2017; 24(7):673-700. PubMed ID: 28093982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma.
    Kim J; Jeong D; Nam J; Aung TN; Gim JA; Park KU; Kim SW
    Gene; 2015 Mar; 558(1):173-80. PubMed ID: 25576220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells.
    Goto M; Murakawa M; Kadoshima-Yamaoka K; Tanaka Y; Inoue H; Murafuji H; Hayashi Y; Miura K; Nakatsuka T; Nagahira K; Chamoto K; Fukuda Y; Nishimura T
    Cell Immunol; 2009; 258(2):147-51. PubMed ID: 19477436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
    Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
    Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells.
    Dong H; Carlton ME; Lerner A; Epstein PM
    Front Pharmacol; 2015; 6():230. PubMed ID: 26528184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utero-relaxant effect of PDE4-selective inhibitor alone and in simultaneous administration with beta2-mimetic on oxytocin-induced contractions in pregnant myometrium.
    Franova S; Janicek F; Visnovsky J; Dokus K; Zubor P; Sutovska M; Nosalova G
    J Obstet Gynaecol Res; 2009 Feb; 35(1):20-5. PubMed ID: 19215543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of breast cancer cell migration by activation of cAMP signaling.
    Dong H; Claffey KP; Brocke S; Epstein PM
    Breast Cancer Res Treat; 2015 Jul; 152(1):17-28. PubMed ID: 26022351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis deregulation influences chemoresistance to azaguanine in human leukemic cell lines.
    Sarmento-Ribeiro AB; Dourado M; Paiva A; Freitas A; Silva T; Regateiro F; Oliveira CR
    Cancer Invest; 2012 Jun; 30(5):331-42. PubMed ID: 22348536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
    Davis TG; Peterson JJ; Kou JP; Capper-Spudich EA; Ball D; Nials AT; Wiseman J; Solanke YE; Lucas FS; Williamson RA; Ferrari L; Wren P; Knowles RG; Barnette MS; Podolin PL
    J Pharmacol Exp Ther; 2009 Sep; 330(3):922-31. PubMed ID: 19498103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhodanine derivatives as novel inhibitors of PDE4.
    Irvine MW; Patrick GL; Kewney J; Hastings SF; MacKenzie SJ
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2032-7. PubMed ID: 18304812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors.
    Sánchez AI; Martínez-Barrasa V; Burgos C; Vaquero JJ; Alvarez-Builla J; Terricabras E; Segarra V
    Bioorg Med Chem; 2013 Apr; 21(8):2370-2378. PubMed ID: 23454131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucocorticoid, interleukin-2, and prostaglandin interactions in a clonal human leukemic T-cell line.
    Johnson BH; Dean RR; Moran SM; Thompson EB
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):1-9. PubMed ID: 1558815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.